Ceribell CBLL
NASDAQ CBLL
$24.20 -0.11 (-0.45%)
At close: Aug 21, 2026 · 4:00 PM EDT

Ceribell (CBLL) Cash & Equivalents Growth (1y) (2024 - 2026)

Ceribell (CBLL) Cash & Equivalents Growth (1y) (2024 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (1y) (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn -26.57%
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn 42.78%
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn -12.13%
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn 0.94%
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn -11.19%
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn -4.66%
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn -44.03%
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn 19.49%
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn 72.43%
10 Ceribell 916.57 Mn 787.31 Mn 25.94 Mn -18.63%

Historic Data

Download Data
DateValue
Jun 30, 2026 -18.63%
Mar 31, 2026 -70.49%
Dec 31, 2025 -79.18%
Sep 30, 2025 68.36%
Dec 31, 2024 463.47%